| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.8M | — | -7.0% |
| Cost of Revenue | $865K | — | -16.3% |
| Gross Profit | $909K | — | +4.0% |
| R&D Expense | $175K | — | +14.4% |
| SG&A Expense | $677K | — | +2.6% |
| Operating Income | -$400K | — | -94.2% |
| Pre-tax Income | -$393K | — | -103.6% |
| Income Tax | $3K | — | +50.0% |
| Net Income | -$396K | — | -103.1% |
| EPS (Basic) | -$0.09 | — | — |
| EPS (Diluted) | -$0.09 | — | — |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $201K | — | +3250.0% |
| Short-term Investments | $100K | +0.0% | -60.0% |
| Accounts Receivable | $686K | +24.1% | +17.3% |
| Current Assets | $1.6M | -23.1% | -31.5% |
| Total Assets | $3.0M | -14.1% | -20.2% |
| Current Liabilities | $1.1M | -14.4% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$570K | — | -860.0% |
| +1.5% |
| Total Liabilities | $1.1M | -14.4% | +1.5% |
| Stockholders' Equity | $1.8M | -13.8% | -29.5% |